AnaptysBio, Inc. short interest in 2021
In 2021, AnaptysBio, Inc.'s disclosed short interest ran from 12.92% of shares outstanding on 15 Jan 2021 to 7.81% on 31 Dec 2021, a change of -5.11 percentage points. The year's high was 15.74% on 15 Apr 2021 and its low 7.81% on 31 Dec 2021, averaging 11.68% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 22.55 days on 31 Aug 2021. Full history: AnaptysBio, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2021 in figures
- Start of year
- 12.92% (15 Jan 2021)
- End of year
- 7.81% (31 Dec 2021)
- Change
- -5.11 pp
- High
- 15.74% (15 Apr 2021)
- Low
- 7.81% (31 Dec 2021)
- Average
- 11.68%
- Highest days to cover
- 22.55 (31 Aug 2021)
- SEC filings marked
- 9
Every report in 2021
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2021 | 12.92% | 7.26 | results (8-K) |
| 29 Jan 2021 | 13.07% | 11.44 | |
| 12 Feb 2021 | 13.67% | 9.92 | |
| 26 Feb 2021 | 13.92% | 11.30 | 10-K filed, results (8-K) |
| 15 Mar 2021 | 14.38% | 3.29 | |
| 31 Mar 2021 | 15.31% | 10.86 | |
| 15 Apr 2021 | 15.74% | 19.35 | |
| 30 Apr 2021 | 14.39% | 17.63 | |
| 14 May 2021 | 14.49% | 18.07 | 10-Q filed, results (8-K) |
| 28 May 2021 | 13.80% | 19.23 | |
| 15 Jun 2021 | 13.87% | 19.93 | |
| 30 Jun 2021 | 11.34% | 8.01 | |
| 15 Jul 2021 | 11.43% | 17.97 | |
| 30 Jul 2021 | 10.63% | 14.17 | |
| 13 Aug 2021 | 10.48% | 22.13 | 10-Q filed, results (8-K) |
| 31 Aug 2021 | 10.59% | 22.55 | |
| 15 Sep 2021 | 10.15% | 19.59 | |
| 30 Sep 2021 | 9.34% | 14.09 | |
| 15 Oct 2021 | 9.01% | 16.56 | |
| 29 Oct 2021 | 8.84% | 12.91 | |
| 15 Nov 2021 | 8.47% | 11.69 | 10-Q filed, results (8-K) |
| 30 Nov 2021 | 8.34% | 12.60 | |
| 15 Dec 2021 | 8.34% | 16.29 | |
| 31 Dec 2021 | 7.81% | 11.88 |
See also: AnaptysBio, Inc.'s full history · most shorted US stocks of 2021 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.